LRIG3 Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP22023a
Background:
May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity).
Other Names:
Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3, LRIG3, LIG3
Target/Specificity:
The synthetic peptide sequence is selected from aa 23-34 of HUMAN LRIG3
Gene Name: LRIG3
Gene ID: 121227
Primary Accession: Q6UXM1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity).
Other Names:
Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3, LRIG3, LIG3
Target/Specificity:
The synthetic peptide sequence is selected from aa 23-34 of HUMAN LRIG3
Gene Name: LRIG3
Gene ID: 121227
Primary Accession: Q6UXM1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review